Avigen is developing a platform technology that selects potent immune cells pre-clinically to streamline, accelerate and de-risk the development of the next generation of cellular immunotherapies.
| Website | https://avigen.bio |
| Employees | 8 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular Avigen employee's phone or email?
Tobias Gamper is the Founder and CEO of Avigen.
1 people are employed at Avigen.